Vara is dedicated to making data-driven breast cancer screening accessible and affordable for women everywhere. Their AI-assisted mammography platform supports early detection, timely diagnosis, and effective treatments to reduce breast cancer mortality globally. Vara collaborates closely with screening units and radiologists to ensure superior technology and user experience that enhances the quality and performance of breast cancer screening.

Founded in 2018 as a spin-off from Merantix Venture Studio, Vara has grown through partnerships with leading screening centers. The company is CE certified as a medical device and has achieved significant milestones, including international expansion and leading major AI studies in breast cancer screening. Vara aims to improve health outcomes by integrating AI into the radiologist workflow for accurate, early breast cancer detection.